Kisspeptin research in cells and people

What Kisspeptin research means for you

Early cancer work found kisspeptin while researchers were studying how cancer spreads, and later tests showed what this brain-made protein does to the hormone chain inside both men and women. The protein starts hormone work tied to sex and birth.

Kisspeptin docks on brain cells and tells them to send out a starter hormone in short bursts ^[2]. Each burst calls the small gland below your brain into action.

That gland releases one hormone that prompts testosterone and egg release. It also releases another that helps sperm and eggs grow.

Human blood tests showed this same order. The first hormone rose most, the second rose less, and testosterone came later ^[8].

Children born without a working docking place for kisspeptin don’t start puberty ^[1]. This is strong proof that the step matters.

I’ll name who was studied before each result. The amounts describe research visits and aren’t directions for you.

What Kisspeptin changed in brain cells

This work used single brain cells in a dish, so it tells you nothing about symptoms. The lab mix held 100 nanomoles per liter, a very small amount of kisspeptin used only to watch how those cells answered when the protein touched their outer walls in a dish.

The cells’ electric charge shifted by 6 millivolts, with about 1 millivolt of normal spread. Their firing rate rose by 87 percent on average, with about 4% of spread between results.

About 75% of the adult cells answered ^[2]. Kisspeptin caused stored calcium to move inside those cells.

That calcium move closed some tiny gates and opened others. The change let charged salts cross the cell wall, which made the cell fire.

Firing made the cells release the starter hormone in bursts. This lab finding can’t tell how you would feel or what your blood test would show.

Nearby brain cells start and stop each hormone burst. Kisspeptin carries their timed order to the cells that release the hormone.

What failed when the Kisspeptin step broke

The first strong proof came from people born without a working docking place for kisspeptin. They didn’t go through puberty ^[1].

Mice born with the same fault also missed puberty. The result showed that this hormone step matters in both people and mice.

Researchers then used kisspeptin as a test. Some people who made too little sex hormone had no rise in the hormone that should prompt their glands ^[12].

That weak reply suggested their trouble lay farther along in the brain. Healthy men given the same kind of test usually had a rise.

Children late to puberty gave mixed replies ^[11]. A strong adult-like rise helped show that puberty had begun inside the body.

I read these findings as clues about where your hormone chain may have stopped. They don’t prove that kisspeptin can fix the cause or help over time.

What Kisspeptin-10 changed in healthy men

Kisspeptin-10 is the short form, made from 10 protein pieces. In a small study, it raised the hormone that prompts testosterone in healthy men.

Researchers put 1 microgram for each kilogram of body weight into a vein. That hormone reached its high point 30 minutes later ^[3].

A slow vein drip also raised the hormone and made its bursts more frequent. At 4 micrograms per kilogram each hour, testosterone rose too.

Kisspeptin-10 and kisspeptin-54 caused much the same hormone reply at matching rates ^[10]. The 10 in the short form’s name counts its protein pieces.

Its useful effect lasts about 4 minutes. That short time can’t promise you a steady or lasting change.

What Kisspeptin-54 changed during longer tests

Kisspeptin-54 is the longer form, once known by another name in cancer work. It stays in blood longer than kisspeptin-10.

Healthy men received a tiny vein drip for 90 minutes in an early study. The rate was 4 trillionths of a mole for each kilogram each minute.

The hormone that prompts testosterone rose most, while two later hormones rose less ^[8]. The blood level of kisspeptin-54 fell by half in about half an hour.

That was about seven times longer than the short form. Researchers used the 54 form when they needed more time to watch the hormone reply.

Men with type 2 diabetes and mildly low testosterone also had a rise after kisspeptin-10 ^[9]. This helps explain why doctors may study the brain as well as the testes.

What changed in periods, fertility care, and nasal use

The missed-period study was small and used a slow vein drip. Women given kisspeptin-54 had more hormone bursts across 8 hours, but the highest amount faded ^[4].

Other work found that kisspeptin and those bursts came close together ^[15]. Stress may quiet the brain cells that make kisspeptin ^[14].

The fertility test was also small. It was a Phase 2 trial, an early test with 60 women at high risk of painful ovary swelling and fluid buildup.

Kisspeptin-54 helped eggs mature in 95% of those women ^[5]. No woman had a moderate, severe, or critical case of the swelling.

The highest live-birth rate was 62%. In 2025, nasal kisspeptin-54 raised the starter hormone in healthy men, healthy women, and women without periods ^[6].

No bad effects were reported during that short test. Keeping the mix for 60 days at 4 °C didn’t show whether repeated nasal use would be safe.

What Kisspeptin research still can’t prove

A 2025 review found 29 human trials published through February 2023 ^[7]. The studies covered puberty, fertility, pregnancy, birth, and breast-feeding.

Most were small, short, and done at only a few hospitals. No study has reached Phase 3, the large final test, and no kisspeptin medicine is approved.

Short studies found that certain hormones rose again and again. They can’t tell you what long use might do.

The kisspeptin gene may act differently in each kind of cancer ^[13]. In many cancers that form lumps, it slowed spread, while in some cases it may have helped growth.

Those mixed cancer findings call for care. A decision to prescribe kisspeptin does not close the research gaps, so those unanswered questions still matter for your health.